The cost of treating high blood pressure in general practice in France

European Journal of Health Economics

Volumn 9, Issue 3, 2008, Pages 229-236

  Tibi Levy, Yaël ^a   De Pouvourville, Gérard ^b   Westerloppe, Jérémie ^c   Bamberger, Marion ^c  

^a CNRS   (France)

^b ESSEC BUSINESS SCHOOL   (France)

^c BRISTOL MYERS SQUIBB   (United States)

Author keywords

Cost; Family practice; Hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; COMORBIDITY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DRUG COST; FEMALE; FOLLOW UP; FRANCE; GENERAL PRACTICE; GENERAL PRACTITIONER; HEALTH CARE COST; HEALTH ECONOMICS; HEALTH STATUS; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OBESITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; DIAGNOSTIC TESTS, ROUTINE; DRUG COSTS; FAMILY PRACTICE; FEMALE; FRANCE; HEALTH CARE COSTS; HUMANS; HYPERTENSION; MALE; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; MIDDLE AGED; OFFICE VISITS; RETROSPECTIVE STUDIES;

EID: 46949094790     PISSN: 16187598     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10198-007-0065-2     Document Type: Article

References (24)

1. Agence Nationale d'Accréditation et d'Evaluation en Santé Management of adults with essential hypertension.: Clinical Practice Recommendations and Economic Data. ANAES, Paris (2000)
2. Alexander, M., Tekawa, I., Hunkeler, E., Fireman, B., Rowell, R., Selby, J. et al.: Evaluating hypertension control in a managed care setting. Arch. Intern. Med 159, 2673-2677 (1999)
3. Barrie, W.: Cost-effective therapy for hypertension. West. J. Med. 164, 303-309 (1996)
4. Berlowitz, D.R., Ash, A.S., Hickey, E.C., Friedman, R.H., Glickman, M., Kader, B., Moskowitz, M.A.: Inadequate management of blood pressure in a hypertensive population. N. Engl. J. Med. 339, 1957-1963 (1998)
5. Burt, V.L., Cutler, J.A., Higgins, M., Horan, M.J., Labarthe, D., Whelton, P. et al.: Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the Health Examinations Surveys, 1960 to 1991. Hypertension 26, 60-69 (1995)
6. Cambou, J-P.: Hypertension artérielle essentielle, risque absolu et décision d'intervention chez le malade hypertendu. Rev. Prat. 49, 503-509 (1999)
7. Chalmers, J., Chusid, P., Cohn, J. et al.: Practice guidelines for primary care physicians. WHO/ISH Hypertension Guidelines. WHO, Geneva (1999)
8. Day, K., Booyens, S.: The cost-effectiveness of managed care regarding chronic medicine prescriptions in a selected medical scheme. Curationis 21, 65-70 (1998)
9. Editions du VIDAL.: Dictionnaire VIDAL 2000, 76th edn. Editions du VIDAL, Paris (2000)
10. Egan, B.M., Lackland, D.T., Williams, B., Gunter, N., Tocharoen, A., Beardon, L.: Health care improvement and cost reduction opportunities in hypertensive medicaid beneficiaries. J. Clin. Hypertens. 3,279-82, 318 (2001)
11. Fender, P., Païta, M., Salavane, B., Ganay, D., Allemand, H.: Dépenses du Régime général de l'Assurance-Maladie en 1994 pour les trente affections de longue durée. Santé Publique 12, 5-19 (2000)
12. Frérot, L., Le Fur, P., Le Pape, A., Sermet, C.: L'hypertension artérielle en France : prévalence et prise en charge thérapeutique. Série résultats-Report n° 1999/09. CREDES, Paris (1999)
13. Hajjar, I., Kotchen, T.A.: Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 2090, 199-206 (2003)
14. Mar, J., Pastor, R., Abasolo, R.: Costs analysis of ambulatory blood pressure monitoring in mild hypertension. Gac. Sanit. 13, 384-90 (1999)
15. Paramore, L.C., Halpern, M.T., Lapuerta, P. et al.: Impact of poorly controlled hypertension on healthcare resource utilization and cost. Am. J. Manag. Care. 7, 389-398 (2001)
16. Poggi, L., Chamontin, B., Lang, T. et al.: Prévalence, traitement et contrôle de l'hypertension artérielle chez les consultants en médecine générale en France en 1994. Arch. Mal. Cœur. Vaiss. 89, 1075-80 (1996)
17. Pozuelo, G., Vergeles-Blanca, J.M., Molina, L., Cordero, J.A., Buitrago, F.: Drug savings and the outpatient monitoring of arterial pressure in a group of hypertensive patients. Aten. Primaria. 15, 329-32 (1997)
18. Schueler K.: Cost-effectiveness issues in hypertension control. Can. J. Public. Health. 85, S54-6 (1994)
19. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.: Sixth report. Arch. Intern. Med. 157, 2413-2446 (1997)
20. Union des Caisses Nationales de Sécurité Sociale Nomenclature Générale des Actes Professionnels.: Nomenclature des Actes de Biologie Médicale. UCANSS, Paris (2000)
21. World Hypertension League. Economics of hypertension control. Bull. World. Health. Organ. 73, 417-24 (1995)
22. WHO-International society of hypertension guidelines for the management of hypertension. J Hypertens. 17, 151-83 (1999)
23. Wolf-Maier, K., Cooper, R.S., Banegas, J.R., Giampaoli, S., Hense, H.W., Joffres, M. et al.: Hypertension prevalence and blood pressure in 6 European countries, Canada, and the United States. JAMA 289, 2363-2369 (2003)
24. Wolf-Maier, K., Cooper, R.S., Kramer, H., Banegas, J.R., Giampaoli, S., Joffres, M. et al.: Hypertension treatment and control in five European countries, Canada and the United States. Hypertension 43, 10-17 (2004)